This Renton WA based study is looking at the possibility of delaying the onset of T1D and improving pancreatic beta cell function.
Study Summary:
Rainier Clinical Research Center in Renton is currently seeking volunteers who have been diagnosed with Type 1 Diabetes within the past 20 years for a Phase 1B clinical trial. The trial is testing the efficacy and tolerability of OPT101 – an investigational drug aimed at both the possibility of delaying the onset of T1D and improving pancreatic beta cell function.
This study is placebo controlled with 2/3rds of the participants receiving the study medication and 1/3rd receiving a placebo. Each infusion will last 30 minutes. Participants will receive 8 infusions of the study drug intravenously at our clinic in Renton throughout the duration of the study. Each infusion will last 30 minutes. The first infusion visit will require an 8-hour observation period at our clinic, with each subsequent appointment requiring a minimum of 2-hour observation at the clinic (two of these visits will include an 8-hour cardiac monitoring). Participants will be closely monitored, and blood will be drawn at each visit.
Visits: This study will have 11 in clinic visits
Compensation: up to $2850 for study completion
If you or someone you know is interested, please reach out to the RCRC Lead:
Cely at 425-970-1321 or email at recruitment@rainier-research.com